Literature DB >> 17476702

Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners.

Elizabeth Roughead1, Nicole Pratt, Robert Peck, Andrew Gilbert.   

Abstract

PURPOSE: To determine if patient-specific prescriber feedback for general medical practitioners (GPs), supported by educational material mailed to their patients, would increase home medicines review (HMR) rates.
METHODS: An observational study was conducted using the Repatriation Pharmaceutical Benefits Scheme (RPBS) Pharmacy Claims Database. The intervention group (n = 40 270) included all veterans aged >/=65 years, dispensed >/=5 unique medicines each month over a 4 month period. Comparison group veterans (n = 49,227) were those who did not have >/=5 or more unique medicines dispensed each month, but did have at least one prescription each month and >/=20 prescriptions over 4 months, of which five were unique medicines, Intervention GPs (n = 11,384) were subdivided into 2 groups: GPs with intervention veterans (n = 2097) and GPs with both intervention and comparison group veterans (n = 9287). The comparison group of GPs (n = 3630) were primary prescribers to the comparison veterans only. Rates of HMRs pre and post-intervention and the number of new GPs participating in HMR services were examined.
RESULTS: There was a significant increase in HMR rates in intervention group, from 2.2 per 1000 in the pre-period to 4.6 per 1000 per month in the post-intervention period (Rate Ratio (RR) 2.06, 95% Confidence Interval (CI) (1.90, 2.22), p < 0.0001). HMR rates increased in the intervention group compared with the comparison group (p < 0.0001). HMR rates increased in the intervention group GPs compared with the comparison group (RR 1.79, 95% CI (1.58, 2.02), p < 0.0001).
CONCLUSION: Patient-specific feedback provided to GPs, supported by educational material mailed directly to their patients increased HMR rates for targeted veterans and increased GP participation in the delivery of HMRs.

Entities:  

Mesh:

Year:  2007        PMID: 17476702     DOI: 10.1002/pds.1393

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  10 in total

1.  Challenges in chronic illness management: a qualitative study of Australian pharmacists' perspectives.

Authors:  Elin C Lehnbom; Jo-anne E Brien
Journal:  Pharm World Sci       Date:  2010-07-14

2.  Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany.

Authors:  Thomas Fiss; Christoph Alexander Ritter; Dietrich Alte; Neeltje van den Berg; Wolfgang Hoffmann
Journal:  Pharm World Sci       Date:  2010-07-01

3.  Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors use in Australia and Nova Scotia (Canada).

Authors:  Nadia Barozzi; Ingrid Sketris; Charmaine Cooke; Susan Tett
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

4.  A pharmacist-led intervention for increasing the uptake of Home Medicines Review (HMR) among residents of retirement villages (PHARMER): protocol for a cluster randomised controlled trial.

Authors:  Cik Yin Lee; Johnson George; Rohan A Elliott; Kay Stewart
Journal:  BMC Health Serv Res       Date:  2011-10-31       Impact factor: 2.655

Review 5.  Interventions to improve the appropriate use of polypharmacy for older people.

Authors:  Audrey Rankin; Cathal A Cadogan; Susan M Patterson; Ngaire Kerse; Chris R Cardwell; Marie C Bradley; Cristin Ryan; Carmel Hughes
Journal:  Cochrane Database Syst Rev       Date:  2018-09-03

6.  Medication reviews are useful, but the model needs to be changed: Perspectives of Aboriginal Health Service health professionals on Home Medicines Reviews.

Authors:  Lindy Swain; Lesley Barclay
Journal:  BMC Health Serv Res       Date:  2015-09-10       Impact factor: 2.655

7.  The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians.

Authors:  Sallie-Anne Pearson; Andrea Schaffer
Journal:  BMJ Open       Date:  2014-05-02       Impact factor: 2.692

8.  Safer Prescribing and Care for the Elderly (SPACE): a cluster randomised controlled trial in general practice.

Authors:  Katharine A Wallis; Carolyn Raina Elley; Simon A Moyes; Arier Lee; Joanna F Hikaka; Ngaire M Kerse
Journal:  BJGP Open       Date:  2022-03-22

9.  Evaluation of an interactive program for preventing adverse drug events in primary care: study protocol of the InPAct cluster randomised stepped wedge trial.

Authors:  Maud Keriel-Gascou; Karine Buchet-Poyau; Antoine Duclos; Muriel Rabilloud; Sophie Figon; Jean-Pierre Dubois; Jean Brami; Thierry Vial; Cyrille Colin
Journal:  Implement Sci       Date:  2013-06-19       Impact factor: 7.327

10.  Improving patient self-reporting of antihypertensive adverse drug events in primary care: a stepped wedge cluster randomised trial.

Authors:  Karine Buchet-Poyau; Pauline Occelli; Sandrine Touzet; Carole Langlois-Jacques; Sophie Figon; Jean-Pierre Dubois; Antoine Duclos; Marc Chanelière; Cyrille Colin; Muriel Rabilloud; Maud Keriel-Gascou
Journal:  BMC Fam Pract       Date:  2021-08-07       Impact factor: 2.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.